Aspects of the gastric acid antisecretory activity of 3,3-dimethyl-1- (3-methylaminopropyl) -1-phenylphthalan: a blocker of norepinephrine uptake
Lippmann, W.
Archives Internationales de Pharmacodynamie et de Therapie 193(2): 340-356
1971
ISSN/ISBN: 0003-9780 PMID: 5119219 Document Number: 43418
Document emailed within 1 workday
Related Documents
Murmann, W.; Carminati, G.M.; Cattaneo, R. 1974: Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. III). Gastric antisecretory activity, antagonism against acid hypersecretion induced by pentagastrin and histamine, and other effects Panminerva Medica 16(10): 335-346Zarghi, A.; Faizi, M.; Abdolahnejad, R.; Fassihi, A. 2003: Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates Bollettino Chimico Farmaceutico 142(4): 175-179
Barzaghi, F.; Cesana, R.; Delevallée, F.; Fournex, R.; Nencioni, A.; Vincent, J.C.; Deraedt, R. 1985: Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086) Arzneimittel-Forschung 35(9): 1412-1416
Czeglédi, B.; Zsoldos, T.; Mózsik, G. 1984: Effect of PGF2 alpha administered in cytoprotective and antisecretory doses on the ethanol- and HCl-induced gastric mucosal damage and gastric mucosal superoxide dismutase activity in rats Acta Physiologica Hungarica 64(3-4): 331-337
Valcavi, U.; Caponi, R.; Brambilla, A.; Palmira, M.; Minoja, F.; Bernini, F.; Musanti, R.; Fumagalli, R. 1982: Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals Arzneimittel-Forschung 32(6): 657-663
Suzuki, A.; Kumano, H.; Osaka, S.; Shiomi, Y.; Moroi, K.; Ishimura, N.; Nishiwada, M. 1996: The effects of preoperative drinking and H2 blocker on gastric acid secretion Masui. Japanese Journal of Anesthesiology 45(4): 445-448
Nielsen, S.T.; Dove, P.A.; Strike, D.P.; Schiehser, G.A. 1987: Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity Drugs under Experimental and Clinical Research 13(5): 297-304
Roszkowski, A.P.; Garay, G.L.; Baker, S.; Schuler, M.; Carter, H. 1986: Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester Journal of Pharmacology and Experimental Therapeutics 239(2): 382-389
Browning, R.A.; Wade, D.R.; Marcinczyk, M.; Long, G.L.; Jobe, P.C. 1989: Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat Journal of Pharmacology and Experimental Therapeutics 249(1): 229-235
Matlib, M.A. 1985: Action of bepridil, a new calcium channel blocker on oxidative phosphorylation, oligomycin-sensitive adenosine triphosphatase activity, swelling, Ca++ uptake and Na+-induced Ca++ release processes of rabbit heart mitochondria in vitro Journal of Pharmacology and Experimental Therapeutics 233(2): 376-381
Varnavas, A.; Nisi, C.; Lassiani, L.; Sava, G.; Perissin, L.; Boccù, E. 1991: Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt Arzneimittel-Forschung 41(11): 1168-1172
Campo de Juan, M.; Vila Moneny, J.; Marques Gaspar, C.; Sanz López, J. 1996: When are we prescribing gastric antisecretory agents? Atencion Primaria 18(8): 467
Kojima, K. 1984: Effect of vagotomy on gastric wall autonomic responses, mucosal cholinesterase activity and gastric acid secretion in cats Nihon Geka Gakkai Zasshi 85(10): 1274-1287
Mugridge, K.G.; Perretti, M.; Ghiara, P.; Galeotti, C.L.; Melli, M.; Parente, L. 1995: Gastric antisecretory and anti-ulcer actions of IL-1 in rat involve different IL-1 receptor types American Journal of Physiology 269(5 Pt 1): G763-G769
Pellegrini, R.; Abbondati, G. 1976: Trithiozine (ISF 2001): gastric antisecretory effects and treatment of peptic ulcer Il Farmaco; Edizione Pratica 31(10): 483-494
Dajani, E.Z.; Bianchi, R.G.; Casler, J.J.; Weet, J.F. 1979: Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats Archives Internationales de Pharmacodynamie et de Therapie 242(1): 128-138
Galmiche, J.P.; Mignon, M.; Ducrotte, P.; Mayeur, S.; Arsene, D.; Vallot, T. 1981: Continuous recording of gastric pH to assess the efficacy of antisecretory drugs in Zollinger-Ellison syndrome La Nouvelle Presse Medicale 10(6): 432-433
White, D.J. 1991: Reactivity of fluoride dentifrices with artificial caries. III. Quantitative aspects of acquired acid resistance (AAR): F uptake, retention, surface hardening and remineralization Journal of Clinical Dentistry 3(1): 6-14
Eysselein, V.E. 1987: New aspects of the neural regulation of gastric acid secretion Zeitschrift für Gastroenterologie. Verhandlungsband 22: 91-96
Davila, D.; Khairallah, P.A. 1970: Effect of ions on inhibition of norepinephrine uptake by angiotensin Archives Internationales de Pharmacodynamie et de Therapie 185(2): 357-364